Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Robson

Showing results (211-220 of 352) with videos related to

Pageof 36
Sort By:
Journal of Medical Genetics|August 6, 2002
Incidence of non-founder BRCA1 and BRCA2 mutations in high risk Ashkenazi breast and ovarian cancer familiesN D Kauff, P Perez-Segura, M E Robson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 1, 1993
Phase II study of fluorouracil, leucovorin, and interferon alfa-2a in metastatic colorectal carcinomaJ L Grem, E Jordan, M E Robson, et al.
Cancer|October 15, 2008
Proceedings of the international consensus conference on breast cancer risk, genetics, & risk management, April, 2007Gordon F Schwartz, Kevin S Hughes, Henry T Lynch, et al.
Research Square|June 17, 2024
Intratumoral Fc-optimized agonistic CD40 antibody induces tumor rejection and systemic antitumor immunity in patients with metastatic cancerJuan C Osorio, David A Knorr, Polina Weitzenfeld, et al.
Journal of Skin Cancer|August 12, 2022
Interest and Utility of <i>MC1R</i> Testing for Melanoma Risk in Dermatology Patients with a History of Nonmelanoma Skin CancerJennifer L Hay, Erica H Lee, Stephanie N Christian, et al.
Cancer Research|August 4, 2004
Increased progesterone receptor expression in benign epithelium of BRCA1-related breast cancersTari A King, Mary L Gemignani, Weiwei Li, et al.
Annals of Surgical Oncology|June 29, 2007
Heterogenic loss of the wild-type BRCA allele in human breast tumorigenesisTari A King, Weiwei Li, Edi Brogi, et al.
Breast Cancer Research and Treatment|November 3, 2016
Characterization of a novel germline PALB2 duplication in a hereditary breast and ovarian cancer familyCiyu Yang, Angela G Arnold, Magan Trottier, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 14, 2016
Conflicting Interpretation of Genetic Variants and Cancer Risk by Commercial Laboratories as Assessed by the Prospective Registry of Multiplex TestingJudith Balmaña, Laura Digiovanni, Pragna Gaddam, et al.
JCO Precision Oncology|July 12, 2021
Tolerability of Breast Radiotherapy Among Carriers of <i>ATM</i> Germline VariantsLeslie A Modlin, Jessica Flynn, Zhigang Zhang, et al.
Pageof 36

Showing results (211-220 of 352) with videos related to

Sort By:
Pageof 36
Journal of Medical Genetics|August 6, 2002
Incidence of non-founder BRCA1 and BRCA2 mutations in high risk Ashkenazi breast and ovarian cancer familiesN D Kauff, P Perez-Segura, M E Robson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 1, 1993
Phase II study of fluorouracil, leucovorin, and interferon alfa-2a in metastatic colorectal carcinomaJ L Grem, E Jordan, M E Robson, et al.
Cancer|October 15, 2008
Proceedings of the international consensus conference on breast cancer risk, genetics, & risk management, April, 2007Gordon F Schwartz, Kevin S Hughes, Henry T Lynch, et al.
Research Square|June 17, 2024
Intratumoral Fc-optimized agonistic CD40 antibody induces tumor rejection and systemic antitumor immunity in patients with metastatic cancerJuan C Osorio, David A Knorr, Polina Weitzenfeld, et al.
Journal of Skin Cancer|August 12, 2022
Interest and Utility of <i>MC1R</i> Testing for Melanoma Risk in Dermatology Patients with a History of Nonmelanoma Skin CancerJennifer L Hay, Erica H Lee, Stephanie N Christian, et al.
Cancer Research|August 4, 2004
Increased progesterone receptor expression in benign epithelium of BRCA1-related breast cancersTari A King, Mary L Gemignani, Weiwei Li, et al.
Annals of Surgical Oncology|June 29, 2007
Heterogenic loss of the wild-type BRCA allele in human breast tumorigenesisTari A King, Weiwei Li, Edi Brogi, et al.
Breast Cancer Research and Treatment|November 3, 2016
Characterization of a novel germline PALB2 duplication in a hereditary breast and ovarian cancer familyCiyu Yang, Angela G Arnold, Magan Trottier, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 14, 2016
Conflicting Interpretation of Genetic Variants and Cancer Risk by Commercial Laboratories as Assessed by the Prospective Registry of Multiplex TestingJudith Balmaña, Laura Digiovanni, Pragna Gaddam, et al.
JCO Precision Oncology|July 12, 2021
Tolerability of Breast Radiotherapy Among Carriers of <i>ATM</i> Germline VariantsLeslie A Modlin, Jessica Flynn, Zhigang Zhang, et al.
Pageof 36